OrthoPediatrics Corp. reported a record third-quarter revenue of $72.7 million, up 19% year-over-year, and increased its 2026 financial guidance range to $270.0 million to $273.0 million.
OrthoPediatrics Corp. reported a record third-quarter revenue of $72.7 million, up 19% year-over-year, and increased its 2026 financial guidance range to $270.0 million to $273.0 million.